AI as a signal assessor - Can a Large Language Model perform causality assessment on a case series?
Shenoy, A.; Zekarias, A.; Viklund, A.; Mitchell, J.; Barrett, J.; Sandberg, L.; Meldau, E.-L.; Taavola-Gustafsson, H.
Show abstract
Background Large Language Models (LLMs) are increasingly explored for pharmacovigilance tasks, including information extraction, case documentation, and single-case causality assessment. However, their ability to support causality assessment at the case series level -- a complex, time-intensive task requiring clinical reasoning across multiple reports -- remains unexplored. Objective To investigate how a large-scale general-purpose LLM can support pharmacovigilance professionals in assessing causality in a case series, and to explore how prompt design influences the quality of the model's reasoning. Methods GPT-4o was used to assess causality for five drug - adverse event combinations, using an adaptation of the Bradford Hill viewpoints for case series assessment. The combinations represented varying drugs and vaccines, adverse events, and case series sizes (5-402 reports). One combination served as a negative control. Structured prompts were iteratively developed and refined using one combination, then applied to all combinations. LLM-generated assessments for each viewpoint were qualitatively evaluated by human annotators for accuracy (precision), and the LLM's coverage of key aspects from the original signal text was assessed for one combination (recall). Results Across all five combinations, annotators agreed with 79-92% of the LLM's output sentences. Full disagreement was consistently low (3-7%), with errors typically involving misinterpretation of complex report details rather than outright fabrication. Prompt design substantially influenced output quality; providing Bradford Hill viewpoint descriptions, including case series data, and adding explicit anti-hallucination instructions improved specificity and grounding. For the recall assessment, 15 of 23 key segments from the original signal text were reflected in the LLM output. The overall summary assessments demonstrated balanced reasoning, correctly distinguishing between positive safety signals and the negative control, and provided a coherent synthesis suitable as a starting point for human assessors. Conclusions LLMs have the potential to generate contextually nuanced and largely accurate preliminary causality assessments of case series aligned with the Bradford Hill viewpoints, with a low but non-zero hallucination rate. These findings support LLMs as a tool to augment, not replace, expert judgment in signal assessment. Future work should address larger and more diverse signal sets, improved evaluation frameworks for generative output, and the integration of pre-computed summary statistics to reduce errors.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Large-scale empirical identification of candidate comparators for pharmacoepidemiological studies 95%
- Standardization of drug names in the FDA Adverse Event Reporting System: The DiAna dictionary 94%
- Patient-Reported Reasons for Antihypertensive Medication Change: A Quantitative Study Using Social Media 93%
Similar papers in this journal
Similar papers in this journal
Similar papers in this journal
- Algorithmic identification of treatment-emergent adverse events from clinical notes using large language models: a pilot study in inflammatory bowel disease 94%
- Pathway-based similarity measurement to quantify transcriptomics similarity between human tissues and preclinical models. 91%
- DrugWAS: Leveraging drug-wide association studies to facilitate drug repurposing for COVID-19 90%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.